Wayne Batchelor News Today

In patients who had revascularization after an acute MI and had a preserved EF, long-term beta-blocker use showed no benefit compared with no beta-blockers, in REDUCE-AMI.

Ticagrelor monotherapy safely cut bleeding by more than half after intervention for acute coronary syndrome, without an increase in MACCE, in the ULTIMATE-DAPT trial.

In the largest randomized clinical trial and first of its kind to date in the United States, a team led by investigators at Beth Israel Deaconess Medical Center (BIDMC) assessed the efficacy and safety of using a drug-coated balloon in patients undergoing coronary angioplasty.

In the largest randomized clinical trial and first of its kind to date in the United States, a team led by investigators at Beth Israel Deaconess Medical Center

In the largest randomized clinical trial and first of its kind to date in the United States, a team led by investigators at Beth Israel Deaconess Medical Center

Clinicians question the group's methodology, but the Lown Institute, that produced the report, stands by its methods and conclusions.

Cardiologists are challenging a report that suggests 1 in 5 stents placed in Medicare recipients were unnecessary.

Even after medical therapy was intensified in both groups, fewer medications were needed after denervation than after sham.

The benefits observed with edge-to-edge repair were greater in patients with worse baseline status.

Operators have a choice of two devices, Neal Kleiman says. “I’m glad to see we’ve got a field that’s evolving and competitive.”